Primary Health Care Limited (ASX:PRY) share price sinks lower on bearish broker note

One of the worst performers on the market on Tuesday has been the Primary Health Care Limited (ASX: PRY) share price.

In afternoon trade the leading pathology and GP network operator’s shares are down 4% to $2.36.

Why are Primary Health Care’s shares tumbling lower?

With no news out of the company, today’s decline is likely to be attributable to a note out of Goldman Sachs this morning.

It has initiated coverage on both Primary Health Care and Sonic Healthcare Limited (ASX: SHL) in its note. And while it has placed a neutral rating on Sonic Healthcare’s shares, it hasn’t been so kind to Primary Health Care.

According to the note, it has slapped a sell rating and $2.23 price target on the company’s shares.

Why is Goldman Sachs bearish on Primary Health Care?

Goldman believes that things are likely to get worse for the company before they get better.

The broker believes that its Pathology business could be a drag on its performance this year. It expects the business to be negatively impacted by lower volumes caused by an Australian flu season which was the most benign since 2013.

But there are potential positives on the horizon that could make Primary Health Care worth considering in the future.

Goldman sees a lot of promise from its Medical Centres business. This business has faced a series of challenges in recent times and been largely responsible for its share price underperformance since FY 2015.

And while the broker believes it is too early to call the bottom here, if and when this business can be turned around, its analysts see a significant amount of value accretion.

In respect to Sonic Healthcare’s neutral rating, the broker feels the global pathology provider’s shares are priced correctly to account for the risks facing its U.S. business and pricing reforms in Germany.

What now?

While Goldman may not be bullish on these two shares or private health insurer Medibank Private Ltd (ASX: MPL), it recently gave Australia and New Zealand Banking Group (ASX: ANZ) a buy rating.

I agree with this rating and think it is well worth considering the bank if you haven’t already got meaningful exposure to the sector.

But if you're not keen on the banks then check out this fast-growing dividend share which has also been tipped as a buy.

OUR #1 dividend pick to grow your wealth now is revealed for FREE here!

You might not know this market leader's name, but it's rapidly expanding into a highly profitable niche market here in Australia. Even better, the shares boast a strong, fully franked dividend that should balloon in the years to come. In other words, we're looking at the holy grail of incredible long-term growth potential AND income you can watch accruing in your account in real time!

Simply click here to grab your FREE copy of this up-to-the-minute research report on our #1 dividend share recommendation now.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

5 ASX Stocks for Building Wealth After 50

I just read that Warren Buffett, the world’s best investor, made over 99% of his massive fortune after his 50th birthday.

It just goes to show you… it’s never too late to start securing your financial future.

And Motley Fool Chief Investment Advisor Scott Phillips just released a brand-new report that reveals five of our favourite ASX stocks for building wealth after 50.

– Each company boasts strong growth prospects over the next 3 to 5 years…

– Most importantly each pays a generous dividend, fully franked.

Simply click here to find out how you can claim your FREE copy of “5 ASX Stocks for Building Wealth After 50.”

See the stocks now